Therapeutic relevance of altered cytokine expression

被引:38
作者
Kulmatycki, KM [1 ]
Jamali, F [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
D O I
10.1006/cyto.2000.0827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokines and their receptors have numerous physiological functions. Altered concentrations of these mediators are associated with various afflictions. For example, over-expression of cytokines has been associated with altered drug concentrations and activity. Greater concentrations of cardiovascular drugs have been observed in humans and laboratory animals with various types of inflammatory disorders compared to healthy controls. Interestingly, the observed higher concentrations of drugs such as propranolol and verapamil have not been associated with increased effects. Indeed, reduced response to these cardiovascular drugs is observed, suggestive of cytokine-mediated downregulation of receptors, Increased cytokine concentrations have also been associated with decreased response to drugs used in treatment of other disorders such as AIDS, asthma and psychiatric diseases. This reduced response to drug in the presence of altered cytokine concentrations. is especially relevant to the elderly population which has a greater incidence of multiple diseases and elevated concentrations of various cytokines compared to younger individuals. Furthermore, inflammatory conditions and their accompanied increased over-expression of cytokines are suggested to be the main determinants of therapeutic failure in myocardial infarction and angina. Therefore, altered cytokine concentrations may influence therapeutic outcomes of pharmacotherapy and result in treatment failure. (C) 2001 Academic Press.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 136 条
[1]   VERAPAMIL PHARMACODYNAMICS AND DISPOSITION IN YOUNG AND ELDERLY HYPERTENSIVE PATIENTS - ALTERED ELECTROCARDIOGRAPHIC AND HYPOTENSIVE RESPONSES [J].
ABERNETHY, DR ;
SCHWARTZ, JB ;
TODD, EL ;
LUCHI, R ;
SNOW, E .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) :329-336
[2]  
ABERNETHY DR, 1993, J PHARMACOL EXP THER, V266, P904
[3]  
ABERNETHY DR, 1988, J CARDIOVASC PHARM, V11, P209
[4]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[5]  
[Anonymous], 1999, Neurology, V53, P457
[6]  
Arakawa T, 1998, DIGEST DIS SCI, V43, p61S
[7]   The role of cytokines and chemokines on tumor progression: A review [J].
Ardestani, SK ;
Inserra, P ;
Solkoff, D ;
Watson, RR .
CANCER DETECTION AND PREVENTION, 1999, 23 (03) :215-225
[8]   Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-β [J].
Arteaga, CL ;
Koli, KM ;
Dugger, TC ;
Clarke, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (01) :46-53
[9]   Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy:: Persistent TNF activation is associated with virologic and immunologic treatment failure [J].
Aukrust, P ;
Müller, F ;
Lien, E ;
Nordoy, I ;
Liabakk, NB ;
Kvale, D ;
Espevik, T ;
Froland, SS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :74-82
[10]   Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis [J].
Badolato, R ;
Oppenheim, JJ .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1996, 26 (02) :526-538